Johnson & Johnson (JNJ) reported stronger-than-expected earnings. Goldman Sachs Global Investment Research head of the healthcare business Asad Haider joins Catalysts with Madison Mills and StoneX senior adviser Jon Hilsenrath to take a closer look at the earnings print and Johnson & Johnson’s position as US President Donald Trump pushes for tariffs on pharmaceutical imports. To watch more expert insights and analysis on the latest market action, check out more Catalysts here: https://finance.yahoo.com/videos/seri… #youtube #stocks #tech #apple #tesla About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. Get the latest news and data at finance.yahoo.com
